US FDA Suspends Domestic Inspections As Staff Work Remotely In Covid-19 Response
Exceptions will be made for inspections of facilities manufacturing medically necessary products, such as products to treat and prevent Covid-19, the disease caused by the virus, and breakthrough products such as cancer treatments.
You may also be interested in...
Turkish firm Gulsah Uretim Kozmetik Sanayi Anonim Sirketi is latest OTC manufacturer warned GMP violations based on records submitted in response to requests CDER submitted in March and April 2020.
Compliance experts see possibilities in offering video tours as the FDA offers “holistic” approach to assessing sites during pandemic.